Stiolto Respimat (Boehringer Ingelheim Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Stiolto Respimat drug offered from Boehringer Ingelheim Pharmaceuticals Inc.. This Anticholinergic [EPC],Cholinergic Antagonists [MoA],beta2-Adrenergic Agonist [EPC],Adrenergic beta2-Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | tiotropium bromide and olodaterol |
| SUBSTANCE NAME: | TIOTROPIUM BROMIDE MONOHYDRATE; OLODATEROL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA],beta2-Adrenergic Agonist [EPC],Adrenergic beta2-Agonists [MoA] |
| ROUTE: | RESPIRATORY (INHALATION) |
| DOSAGE FORM: | SPRAY, METERED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-05-21 |
| END MARKETING DATE: | 0000-00-00 |
Stiolto Respimat HUMAN PRESCRIPTION DRUG Details:
| Item Description | Stiolto Respimat from Boehringer Ingelheim Pharmaceuticals Inc. |
| LABELER NAME: | Boehringer Ingelheim Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3.124; 2.736(ug/1; ug/1) |
| START MARKETING DATE: | 2015-05-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0597-0155_a7181c67-0e79-017a-eaf1-960e233edfac |
| PRODUCT NDC: | 0597-0155 |
| APPLICATION NUMBER: | NDA206756 |
Other TIOTROPIUM BROMIDE MONOHYDRATE; OLODATEROL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
